Physician profile
Eric E Simon
NPI 1689765752
$1,335.86
in general payments reported to CMS, 2019-2025
16 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $40.21 · 2021: $115 · 2023: $194 · 2024: $167 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.48 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $230.71 | 2024-2025 | Tavneos, Krystexxa |
| Vifor Pharma, INC. | $147.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $129.43 | 2025 | |
| Akebia Therapeutics INC | $128.25 | 2019-2024 | Vafseo |
| Mallinckrodt Enterprises LLC | $120.93 | 2019 | |
| Mallinckrodt Hospital Products INC. | $106.35 | 2024-2025 | Acthar, Terlivaz |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $100.23 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.12 | 2021 | |
| Nxstage Medical, INC. | $73.16 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $55.00 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $49.60 | 2019-2024 | Jynarque |
| Genzyme Corporation | $40.28 | 2019-2023 | |
| Idorsia Pharmaceuticals US INC | $21.69 | 2025 | Tryvio |
| Travere Therapeutics, INC. | $20.55 | 2023 | |
| Shire North American Group INC | $16.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.